Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Title/Summary: Tender for the supply of the chemotherapy drug Fluorouracil in Ostrava, Czech Republic, issued by Fakultní nemocnice Ostrava. The estimated value of the contract is approximately 4,135,588 CZK, with a submission deadline of December 15, 2026.
Scope Of Work: The contract involves the ongoing and repeated supply of the medicinal product 'Cytostatikum s účinnou látkou Fluorouracilum 50 mg in 1 ml injectable/infusion solution for intravenous administration'. The supplies must comply with the specifications outlined in the tender documents and their appendices.
Qualification Criterion: Bidders must meet the eligibility criteria as specified in the tender documents, which include relevant experience in supplying medicinal products, technical capabilities, and compliance with applicable regulations. Mandatory submissions and documentation will be required as part of the bidding process.
Purchaser contact is for registered users
Login to see detailsTender details are for registered users
Login to see details| Tender | Country | TOT Ref. No. | Bid deadline |
|---|---|---|---|
| Medicinal Product of Atc Group J06ba02 with the Active Substance Immunoglobulins, Normal Human, for Intravascular Application | Czech Republic | 152654081 | 18 Dec 2026 |
| Skiagraphic X-Ray Equipment Including Full Service Provision | Czech Republic | 152653770 | 15 Dec 2026 |
| Medicinal Product of Atc Group L04ac21 with the Active Substance Bimekizumab | Czech Republic | 152653613 | 18 Dec 2026 |
| Medicinal Product of Atc Group N02cd07 with the Active Substance Atogepant | Czech Republic | 152653358 | 18 Dec 2026 |
| Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab | Czech Republic | 152647180 | 18 Dec 2026 |